Avitriptan
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 1-[3-[3-[4-(5-methoxypyrimidin-4-yl)piperazin-1-yl]propyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 151140-96-4 |
| ATC code | ? |
| PubChem | CID 133081 |
| ChemSpider | 117442 |
| UNII | 6RS056L04P |
| Chemical data | |
| Formula | C22H30N6O3S |
| Mol. mass | 458.58 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Avitriptan (BMS-180,048) is an anti-migraine drug of the triptan class.[1] It acts as a 5-HT1B and 5-HT1D receptor agonist.[1] It has yet to be marketed.
[edit] See also
[edit] References
- ^ a b Saxena PR, De Vries P, Wang W, et al. (February 1997). "Effects of avitriptan, a new 5-HT 1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential". Naunyn-Schmiedeberg's Archives of Pharmacology 355 (2): 295–302. PMID 9050026. http://link.springer.de/link/service/journals/00210/bibs/7355002/73550295.htm.
|
| This analgesic-related article is a stub. You can help Wikipedia by expanding it. |

